DuPont triumphs over Trian in landmark proxy war

• Autores: Kasia Patel
• Localización: Industrial Minerals, ISSN 0019-8544, Nº. 573, 2015 (Ejemplar dedicado a: Junio)
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • [Ellen Kullman] opposed the granting of four board seats to Trian, including one to CEO Nelson Peltz, on the basis that its strategy for DuPont was expensive, risky and lacked a fundamental understanding of how the chemicals company worked, not least because Trian had initially pledged to cut R&D spending.

    He added that DuPont's shares had spiked in response to events reflecting Trian's involvement in the company, demonstrating market support for Trian joining management.

    Egan-Jones Ratings Co. recommended in May that shareholders vote for all four of Trian's nominees, including Peltz, while influential proxy advisory firm Institutional Shareholder Services (ISS) backed Trian's proposal to shake-up the DuPont board, suggesting that both Peltz and John Myers be added to the board.